Canada Markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.28+0.58 (+1.37%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 51.83B
Enterprise Value 31.44B
Trailing P/E N/A
Forward P/E 1-8.39
PEG Ratio (5 yr expected) 1-10.38
Price/Sales (ttm)12.64
Price/Book (mrq)3.89
Enterprise Value/Revenue 39.93
Enterprise Value/EBITDA 6-14.73

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 354.97
52 Week Low 320.03
50-Day Moving Average 344.87
200-Day Moving Average 335.01

Share Statistics

Avg Vol (3 month) 3480.84k
Avg Vol (10 day) 3558.43k
Shares Outstanding 542.31M
Float 30.43M
% Held by Insiders 114.54%
% Held by Institutions 189.90%
Shares Short (Dec. 30, 2020) 42.77M
Short Ratio (Dec. 30, 2020) 46.52
Short % of Float (Dec. 30, 2020) 411.73%
Short % of Shares Outstanding (Dec. 30, 2020) 47.40%
Shares Short (prior month Nov. 29, 2020) 43.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin -63.13%
Operating Margin (ttm)-73.09%

Management Effectiveness

Return on Assets (ttm)-12.60%
Return on Equity (ttm)-20.69%

Income Statement

Revenue (ttm)144.89M
Revenue Per Share (ttm)3.90
Quarterly Revenue Growth (yoy)572.90%
Gross Profit (ttm)-97.19M
EBITDA -97.68M
Net Income Avi to Common (ttm)-91.47M
Diluted EPS (ttm)-2.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)241.52M
Total Cash Per Share (mrq)6.46
Total Debt (mrq)61.02M
Total Debt/Equity (mrq)14.68
Current Ratio (mrq)6.08
Book Value Per Share (mrq)11.11

Cash Flow Statement

Operating Cash Flow (ttm)-119.03M
Levered Free Cash Flow (ttm)-127.44M